3 results
Approved WMORecruiting
• To assess the tolerability and safety of the investigational medicinal product
Approved WMORecruiting
Our primary objective is to evaluate whether aSAH patients treated with therapeutic dose nadroparine have a lower 30-days mortality rate compared to aSAH patients treated with prophylactic dose nadroparine.
Approved WMORecruiting
Objectives:To compare the efficacy of Atropine 0.05% to Atropine 0.5% treatment in European children with progressive myopia, and to evaluate the safety, adherence, and reasons for nonresponse.To create an online BIG DATA registry for myopia…